News

Veru Inc. an oncology biopharmaceutical company, today announced positive efficacy and safety results from a double-blind, randomized, placebo-controlled Phase 2 clinical trial…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of…
Read More...

Merck and BioNTech are further expanding their strategic partnership. Merck, in close collaboration with BioNTech, will significantly accelerate the supply of urgently needed lipids and…
Read More...

Moderna, Inc. biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the Singapore Health Sciences Authority (HSA) has approved the interim…
Read More...

AstraZeneca’s Forxiga (dapagliflozin) has been approved in China to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with heart failure…
Read More...

A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces the addition of Bruce Zhang, Director of…
Read More...

Johnson & Johnson announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for…
Read More...

TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group ("TCG"), has announced the expansion of its operations in the USA with the establishment of TCG…
Read More...

Tiziana Life Sciences plc a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the completion of its clinical study…
Read More...

GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19 with the…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced the Swiss Federal Government has increased its confirmed order commitment…
Read More...

Matrix Medical Network announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting…
Read More...

Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – announced that WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.…
Read More...

Ocugen, Inc., and Bharat Biotech announced they have entered into a definitive agreement to co-develop, supply, and commercialize Bharat Biotech’s COVAXIN, an advanced stage…
Read More...

Engrail Therapeutics announced that it has acquired NeuroCycle Therapeutics, a company focused on sub-type selective GABA-A modulation. The acquisition strengthens Engrail’s presence in…
Read More...

Ampio Pharmaceuticals, Inc. a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced early positive data…
Read More...

Aeterna Zentaris Inc. through its wholly-owned subsidiary Aeterna Zentaris GmbH a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests…
Read More...

Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, announced it has entered into an exclusive license agreement with Ono…
Read More...

Gilead Sciences, Inc. and Gritstone Oncology, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration with a…
Read More...